Mergers and Acquisitions

Deal launches Heartstream as a standalone company and marks the start of ECH’s global platform strategy in the pre-hospital emergency medical technology market.

Deal adds capabilities in precision assembly, aseptic high-speed filling and end-of-line automation to Automated Industrial Robotics

Deal is expected to accelerate innovation in cancer diagnostics and expand access to early detection tools at a time when global cancer rates continue to climb

GE HealthCare expects the deal to be completed early next year and immediately contribute to its bottomline.

Acquisition unites Parks Medical and Vascular Technology to create a leading platform for Doppler ultrasound and vascular diagnostic systems.

Acquisition will boost company's wearable device capabilities

Kingswood Capital acquires Drive DeVilbiss Healthcare, enhancing its global reach in essential medical products while retaining the current management team.

Glooko enhances diabetes care by acquiring Monarch Medical, expanding its solutions from outpatient to inpatient glycemic management for improved patient outcomes.

Arlington Capital’s TEAM Technologies acquires TAG3 Engineering to boost its capabilities in the medical device space

The partnership will combine Vyome’s health care industry expertise and resources with Embryyo’s medical technology capabilities, with the goal of advancing smart medical devices that could reshape disease management and treatment.

FTC challenge could potentially impact heart valve innovation and patient access in the TAVR market.

TAO Digital enhances its medtech expertise by acquiring DigitalSoftMinds, boosting capabilities in medical devices and AI-powered solutions for regulated industries.

SK Capital partners with LISI Group to acquire Lisi Medical, enhancing its presence in the life sciences CDMO sector and driving future growth.

TEAM Technologies enhances its medical device manufacturing capabilities by acquiring Duke Empirical, positioning itself for growth in the cardiovascular sector.

Experts warn that expanding health care conglomerates threaten competition, increase costs and limit independent practitioners' autonomy, urging regulatory action.

Move expected to help expand digital health access in underserved communities

Move positions Zimmer Biomet in the foot and ankle space

Combined organization now serves more than 20 million members and 1,700 employers

Under the terms, Boston Scientific will pay about $443 million upfront, plus up to $221 million if regulatory milestones occur.